Alternus Energy Group Plc Completes Business Combination with Clean Earth Acquisitions Corp.
• Alternus Energy Group becomes majority shareholder in Alternus Clean Energy Inc.• Commences trading on NASDAQ under the ticker “ALCE” DUBLIN,...
Read more
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering...
Read moreDSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9)...
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On BlackRock, Inc. – BLK
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of BlackRock, Inc. (“BlackRock” or the...
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Amtech Systems, Inc. – ASYS
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Amtech Systems, Inc. (“Amtech” or...
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Hywin Holdings Ltd. – HYW
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Hywin Holdings Ltd. (“Hywin” or...
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Checkpoint Therapeutics, Inc. – CKPT
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Checkpoint Therapeutics, Inc. (“Checkpoint” or...
Read moreVERSES AI Responds To OTC Markets’ Request Regarding Promotional Activity
VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) -- VERSES AI (CBOE Canada: VERS) (OTCQB: VRSSF) ("VERSES" or the "Company"),...
Read moreLongeveron Announces Closing of $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MIAMI, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing...
Read moreVersus Systems Announces 1-For-16 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
LOS ANGELES, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) announced today that...
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS